Ascendis Pharma A (ASND) Shares Outstanding (Weighted Average) (2016 - 2025)
Ascendis Pharma A (ASND) has disclosed Shares Outstanding (Weighted Average) for 10 consecutive years, with $70.5 million as the latest value for Q4 2025.
- Quarterly Shares Outstanding (Weighted Average) rose 14.04% to $70.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $70.5 million through Dec 2025, up 14.04% year-over-year, with the annual reading at $70.5 million for FY2025, 14.04% up from the prior year.
- Shares Outstanding (Weighted Average) hit $70.5 million in Q4 2025 for Ascendis Pharma A, up from $61.9 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $70.5 million in Q4 2025 to a low of $57.2 million in Q4 2022.
- Historically, Shares Outstanding (Weighted Average) has averaged $62.6 million across 5 years, with a median of $61.9 million in 2024.
- Biggest five-year swings in Shares Outstanding (Weighted Average): fell 8.7% in 2022 and later rose 14.04% in 2025.
- Year by year, Shares Outstanding (Weighted Average) stood at $62.7 million in 2021, then decreased by 8.7% to $57.2 million in 2022, then grew by 5.86% to $60.6 million in 2023, then increased by 2.15% to $61.9 million in 2024, then increased by 14.04% to $70.5 million in 2025.
- Business Quant data shows Shares Outstanding (Weighted Average) for ASND at $70.5 million in Q4 2025, $61.9 million in Q4 2024, and $60.6 million in Q4 2023.